Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.

The basics are , the company is investing in production, plant etc
so the numbers will look bleak on the 21 March
that will upset some people

long term they will reap the rewards

ps
remember my CFN tip at 100p (Oct 04 ish) (mid 186.5 today)
I got in at 100p and then again at 130p

good luck all
aqafresh
7-Mar

aqafresh, Bleak?! I have a feeling you could be right on the button!

Now we seem to be pumping Wafertab, can't see it earning enough with that product to be honest.

It's about time they got XGel up and running and the promised deal with Wyeth. But as they have little hope of getting a machine on the market till at least 2006...I can't see the need for investors to rush in and buy?

Most ramped share on the BB's? Is it worth it?

raytac=miserable sod

All you've got to say renault19, just come out from the ant colony? What a shame. :)

Depends whether you want to buy in at a cheap price Rayrac or wait until these are North of 2 later on this year....

RobinReeve? Where did you think that one up? :)

So later this year then (I've heard that before). No rush then as I say above?

Markets price in many months or even years ahead.. how long depends on the individual share..
Some companies have traded at many multiples of present earnings because of future potential.

Yes, but XGel has been around at least since 1998! No one else seems to be in a rush to use XGel, so why on that basis, should anyone be in a rush to buy the shares?

I have a feeling the interims will be very interesting!

Is that Jumping Joe? :)

up almost 10%

Is there any truth in the rumour they are set to buy/receive (for damages) a substantial stake in SEO ?

i dont think seo woulg give a stake to bprg, they have already put away 1m for the settlement.

AXM Pharma receives $700k order for the first sunkist order which includes bprg dissolve-in-mouth products.

http://www.iccinfo.com/AXIM_Pages/index_News.html

http://www.iccinfo.com/AXIM_Pages/index_News.html

160m forecast from the FMC deal earlier, where has that gone? Should they have forecast that so early?


This from part of the Bioprogress report....

"It is therefore difficult to accurately forecast the Company's financial
performance during the early and pre commercialisation phase of its licensed
technologies. This is a challenge for the Company's management but is offset by
ensuring the company has a strong balance sheet with sufficient cash not only to
underpin the companies financial security while revenues are uncertain but also
to reassure its customers and licensees that it has the financial strength to
survive during the period it is readying its technologies for commercialisation.
This is an important issue for potential licensees as entering into a new
technology licensing agreements involves the commitment of substantial resources
by the licensee.

A strong cash position also enables the Company to delay licensing discussions
for newer technologies like WAFERTABTM until a much later stage in their
commercial development when they are demonstrable. This enables much higher
value to be secured for shareholders from customers or licensees than was
possible in the earlier stages of the Company's development when it had fewer
resources.

The Company will increasingly be able to control and forecast its revenue stream
more accurately, and its financial performance will also stabilise as the XGEL
(R) technologies become demonstrable and the Company can generate revenues by
the sale of machines and film in markets and product fields outside of those it
has already licensed and where licensees control the rate of revenue stream.

The revenue and profit contribution of BioTec Films has been lower than
anticipated in 2004 and this will continue in 2005 as the market for simple
relatively unsophisticated dissolve-in-the-mouth products has matured and become
generic. There is more competition as these products do not require
pharmaceutical standard manufacturing facilities and margins in this sector have
been eroded.


And this from the High Court judgement twix Stanelco and Bioprogress...

"21 March 2005

Stanelco plc ('Stanelco')
Stanelco wins leave to appeal

Stanelco RF Technologies Limited, a subsidiary of Stanelco, the RF (radio
frequency) applications group has been granted leave to appeal over the findings
made against it in its long running dispute with BioProgress Technology Limited.

In the hearing at the High Court on Friday 18th March the Court also stayed all
further proceedings relating to the dispute, including BioProgress' claim for
damages and the process directed at implementing the judge's initial finding
until after the appeal is heard. BioProgress were also ordered to pay 9,750
towards Stanelco's costs for this hearing and an earlier application by
Stanelco. BioProgress were also given leave to appeal the court's trial
judgement.

Ian Balchin, Chief Executive of Stanelco commented:

'This is a very significant result for Stanelco and leaves the way open for us
to appeal the decision of the Patents Court, which we now intend to do. We are
committed to protecting our technology and remain confident in our litigation
against BioProgress that Stanelco will retain access to the technology which we
developed.'"

Doesn't look very good for one of the company's involved?

the short sellers are back in bprg

Yep thats it , blame the shorters !

Maybe its holders waking up and smelling the coffee and the fact that small caps are getting battered across the board regardless of fundamentals.

It seems to me that a supposed sell note was issued by Numis that caused the drop, but I would like to clarify the reliability of Numis and their forecasting!

29 Aug 03
Numis buy rating for Wellinton underwriting price target 110p
share price 29 Aug 03 94.3p
Share price never went above 96 after that and fell to 74.4p

16 Aug 02 Buy Luminar 16 Aug 02 price 679p
Price went up briefly and then went into freefall to 261p on 30/1/03

I can get many more examples.

Brokers note are at best 50/50! Toss a coin...
...............................................




And here is a classic!
Numis...


MARKET COMMENT for WEDNESDAY 23rd FEBRUARY 2005
Numis says add Topps Tiles (TPT.L) (raising the target to 280 pence from 250p)

Oops, what price did it close on 23rd March 05.. oh dear... 189p
one month later!
................................

15:08 Wed 28 April 2004
Numis has a and a buy rating for Amvescap, while cutting its target price to 475p from 530p. Amvescap price that day 384p .. never recovered, fell to 260 and only now is price at 333p

sell rating and 120p price target for Aggreko
Aggreko price that day 156, went to around 140 at then bounced to price now around 170

,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,

Do the opposite... more profitable as I have found out on Num(er)is occasions

Amities/ While short selling in this hoary old chestnut, and ex city darling, BPRG, has always been most common and the higher the s/p goes so conversely the size of the predators with voracious appetites increases, i find myself in total agreement with Dil on this particular occassion in that ALL smallcaps across the board were given a good solid larruping today.No sector was left unspared .ln addition no decent "shorter" EVER opens a short position at the current BPRG s/p which according to my current "shorters manuel" has 62p constituting "true value" and trading at the absolute nadir of its cycle.Now those "in the know" are surely those who run the book and that as why in adition to my own anaylsis, l have employed 62p as my limit, as that is also their assessment of fair value; and thus as far as i will personally venture. l wrote all this on this very thread when BPRG broke out of its 65/75 trading parameter and were sailing high at 80 odd pence recently with big buyers coming from all angles yet everyone poo pooed the very notion; and it was met with a torrent of abuse which left me utterly convinced you cannot argue againt consensus logics on these boards. You either agree or are seen as a right party pooper ,,, .And yet now here we sit with that very notion being a reality . But @ 57p? Even l absolutely refuse to sail against the wind l believe Simon C. { Evil K)) and his army of cronies opened respective substantial short positions recently.That is pure folly i believe.For 57p suggests more than a reasonable buying opertunity.lf BPRG falls below this level in tommorows trading it will only be through sheer panic; and regardless of that factor l cant see it having a sustained downward driving impetus. ln fact i would suggest this s/p yields ample upside with little lasting downside. l personally am not an admirer of BPRG.,but that is a different story, and looking at the mechanics of the market i would suggest it is slightly oversold @ this s/p; and presents a half decent buying oppertunity for many or a case of averaging down for others . ,,,,Sois sages , Faires attention , a'bientot @+ J

BPRG is looking too cheap to be true under 60p. I have bought into it.

On what basis does it look cheap ?